Loading...
About this Episode
Joe and Kyle discuss recent news items, including a new LSD microdose study on acute pain, Compass Pathways filing an application for a NASDAQ listing, and Mind Medicine Australia attempting to de-schedule psilocybin and MDMA.
Hosts & Guests
No transcript available for this episode.
More from Psychedelics Today
View all episodes →
PT 652 - Esme Dark - Psychedelics, Somatics and the Shadow
Psychedelics Today
Mar 25, 20261:14:00pending
PT 651 - Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership,...
Psychedelics Today
Mar 19, 20261:22:23pending
